Joining the previously disparate, Expressionist analyzes and integrates transcriptomics, proteomics, metabolomics and conventional toxicology data in a single software platform.
With the analysis of phenotypic data – clinical chemistry, histopathology, physiology, and stressor data - Genedata Expressionist takes a true cross-omics approach to better biomarkers.
Cross-omics delivers more informative biomarkers than the single technology approach: The prediction of a disease state or mode-of-action of a compound becomes more precise with fewer items needed.
Reliable high-quality biomarkers can benefit pharmaceutical R&D in many ways: informed drug candidate selection, prediction of a compound’s toxicity and mode-of-action, pharmaco-dynamics evaluation, patient stratification, personalized medicine, clinical trial diagnosis etc.
The Expressionist Integrated analysis application note focuses on:
- Combining omics and conventional toxicology data
- Integrating across omics for reliable prediction results
- Validating results using multiple technology platforms
- Analyzing microarrays across versions and generations
Click for a list of supported technologies.
Visit our promotion material page for module brochures, posters and publications.
|
To find out more about Expressionist, demos and pricing, please follow the navigation menus on the right hand side or contact us by using this webform. |